Kymera Therapeutics, Inc 10-K for FY2024
Kymera Therapeutics, Inc. (KYMR)
10-K
2025-02-27
For: 2024-12-31
View Original
Added on
April 10, 2026
About this 10-K
Kymera Therapeutics, Inc filed this 10-K on February 27, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $47.07M
- down 40.1% from $78.59M a year earlier
- Net loss
- $223.86M
- compared with a net loss of $146.96M a year earlier
- Diluted EPS
- -$2.98
- compared with -$2.52 a year earlier